A 12-month follow-up study of the course of body dysmorphic disorder

American Journal of Psychiatry

Volumn 163, Issue 5, 2006, Pages 907-912

  Phillips, Katharine A ^a   Pagano, Maria E ^b   Menard, William ^b   Stout, Robert L ^b  

^a BUTLER HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY DYSMORPHIC DISORDER; DISEASE COURSE; ETHNOLOGY; FEMALE; FOLLOW UP; GENDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RELAPSE; REMISSION; CHRONIC DISEASE; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HOSPITALIZATION; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PROGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE; SOMATOFORM DISORDER; TREATMENT OUTCOME;

ADULT; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; TREATMENT OUTCOME;

EID: 85047699206     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.5.907     Document Type: Article

References (29)

1. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI: Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993; 150:302-308
2. Hollander E, Cohen LJ, Simeon D: Body dysmorphic disorder. Psychiatr Ann 1993; 23:359-364
3. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, Grados MA, Nestadt G: The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000; 48:287-293
4. Otto MW, Wilhelm S, Cohen LS, Harlow BL: Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry 2001; 158:2061-2063
5. Phillips KA: Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis 2000; 188:170-175
6. Veale D, Boocock A, Gournay K, Dryden W, Shah F, Willson R, Walburn J: Body dysmorphic disorder: a survey of fifty cases. Br J Psychiatry 1996; 169:196-201
7. Phillips KA, Diaz S: Gender differences in body dysmorphic disorder. J Nerv Ment Dis 1997; 185:570-577
8. Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970; 126:983-987
9. Phillips KA, Grant JE, Siniscalchi JM, Stout R, Price LH: A retrospective follow-up study of body dysmorphic disorder. Compr Psychiatry 2005; 46:315-321
10. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44:540-548
11. Warshaw MG, Keller MB, Stout RL: Reliability and validity of the Longitudinal Interval Follow-Up Evaluation for assessing outcome of anxiety disorders. J Psychiatr Res 1994; 28:531-545
12. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA: The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry 1998; 155:102-108
13. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI: A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994; 30:179-186
14. Phillips KA, Menard W, Fay C, Weisberg R: Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 2005; 46:317-325
15. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders - Non-Patient Edition (SCID-I/NP), Version 2.0. New York, New York State Psychiatric Institute, Biometrics Research, 1996
16. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK: A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997; 33:17-22
17. Coryell W, Leon A, Winokur G, Endicott J, Keller M, Akiskal H, Solomon D: Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996; 153:483-489
18. March JS, Frances A, Carpenter D, Kahn DA: The expert consensus guideline series: treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997; 58(suppl 4):1-72
19. Phillips KA: Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectr 2002; 7:453-460, 463
20. Phillips KA, Albertini RS, Siniscalchi JM, Khan A, Robinson M: Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiatry 2001; 62:721-727
21. Steketee G, Perry JC, Goisman RM, Warshaw MG, Massion AO, Peterson LG, Langford L, Weinshenker N, Farreras IG, Keller MB: The Psychosocial Treatments Interview for anxiety disorders: a method for assessing psychotherapeutic procedures in anxiety disorders. J Psychother Prac Res 1997; 6:45-61
22. Goisman RM, Warshaw MG, Peterson LG, Rogers MP, Cuneo P, Hunt MF, Tomlin-Albanese JM, Kazin A, Gollan JK, Epstein-Kaye T, Reich JH, Keller MB: Panic, agoraphobia, and panic disorder with agoraphobia: data from a multi-center anxiety disorders study. J Nerv Ment Dis 1994; 182:72-79
23. Cox R: Regression models and life-tables. J R Stat Soc Series B 1972; 34:187-220
24. Keller MB, Lavori PW, Coryell W, Endicott J, Meuller TI: Bipolar I: a five-year prospective follow-up. J Nerv Ment Dis 1993; 181:238-245
25. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea MT: Time to recovery, chronicity and levels of psychopathology in major depression. Arch Gen Psychiatry 1992; 49:809-816
26. Yonkers KA, Bruce SE, Dyck IR, Keller MB: Chronicity, relapse and illness - course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety 2003; 17:173-179
27. Shea MT, Yen S: Stability as a distinction between Axis I and Axis II disorders. J Personal Disord 2003; 17:373-386
28. Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, Simeon D: Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999; 56:1033-1039
29. Phillips KA, Albertini RS, Rasmussen SA: A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 2002; 59:381-388